Donoghue Forlines LLC Amgen Inc Transaction History

Donoghue Forlines LLC

$342 Million
Q3 2024

A detailed history of Donoghue Forlines LLC transactions in Amgen Inc stock. As of the latest transaction made, Donoghue Forlines LLC holds 10,989 shares of AMGN stock, worth $3.06 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares

10,989

Holding current value

$3.06 Million

% of portfolio

1.04%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$309.38 - $337.38 $3.4 Million - $3.71 Million	10,989 New	10,989 $3.54 Million
Q4 2023 Feb 07, 2024	SELL	$255.7 - $288.46 $58,299 - $65,768	-228 Reduced 9.72%	2,118 $610,000
Q3 2023 Nov 06, 2023	BUY	$218.65 - $271.46 $512,952 - $636,845	2,346 New	2,346 $630,000
Q1 2023 May 08, 2023	BUY	$225.79 - $275.2 $19,869 - $24,217	88 Added 5.31%	1,745 $421,000
Q4 2022 Feb 08, 2023	SELL	$229.03 - $291.01 $120,927 - $153,653	-528 Reduced 24.16%	1,657 $435,000
Q3 2022 Nov 07, 2022	SELL	$224.46 - $253.15 $842,847 - $950,578	-3,755 Reduced 63.22%	2,185 $492,000
Q2 2022 Aug 08, 2022	SELL	$230.71 - $256.74 $475,493 - $529,141	-2,061 Reduced 25.76%	5,940 $1.45 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $408,500 - $451,907	1,863 Added 30.35%	8,001 $1.94 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $92,280 - $105,606	-464 Reduced 7.03%	6,138 $1.38 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $88,941 - $104,205	419 Added 6.78%	6,602 $1.4 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $31,299 - $34,724	134 Added 2.22%	6,183 $1.51 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $1.12 Million - $1.31 Million	-5,050 Reduced 45.5%	6,049 $1.51 Million
Q4 2020 Feb 09, 2021	BUY	$216.38 - $257.67 $1.34 Million - $1.6 Million	6,208 Added 126.93%	11,099 $2.55 Million
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $1.15 Million - $1.28 Million	4,891 New	4,891 $1.24 Million
Q2 2020 Aug 10, 2020	SELL	$197.81 - $242.74 $748,315 - $918,285	-3,783 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$182.24 - $241.7 $1.84 Million - $2.43 Million	-10,070 Reduced 72.69%	3,783 $767,000
Q4 2019 Jan 27, 2020	SELL	$189.21 - $243.2 $1.62 Million - $2.09 Million	-8,588 Reduced 38.27%	13,853 $3.34 Million
Q3 2019 Oct 29, 2019	SELL	$174.11 - $208.62 $2.43 Million - $2.91 Million	-13,955 Reduced 38.34%	22,441 $4.34 Million
Q2 2019 Jul 23, 2019	BUY	$166.7 - $195.41 $6.07 Million - $7.11 Million	36,396 New	36,396 $6.71 Million

Others Institutions Holding AMGN

# of Institutions

3,120

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Donoghue Forlines LLC, based on Form 13F filings with the SEC.

News

Stay updated on Donoghue Forlines LLC with notifications on news.

Account

Donoghue Forlines LLC Amgen Inc Transaction History